Payment overview · 2025
General Payments
$96.62
1 reported records · 1 companies
Healthcare provider profile · identity verified
Stephen E. Halpin, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · HANNIBAL, MO · NPI 1346229937
Verified facts
What the public records show
CMS Open Payments records show Stephen E. Halpin, M.D. received $96.62 in general payments during 2025 across 1 reported records.
SK Life Science, Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SK Life Science, Inc. |
SK Life Science, Inc. exact · evidence 2025-04-03 |
$96.62 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $96.62 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Furosemide | Furosemide | 547 | 69 |
| Atorvastatin Calcium | Atorvastatin Calcium | 517 | 64 |
| Levothyroxine Sodium | Levothyroxine Sodium | 379 | 39 |
| Amlodipine Besylate | Amlodipine Besylate | 373 | 40 |
| Eliquis | Apixaban | 354 | 40 |
| Potassium Chloride | Potassium Chloride | 343 | 47 |
| Myrbetriq | Mirabegron | 342 | 22 |
| Donepezil Hcl | Donepezil Hcl | 315 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 315 | 30 |
| Pantoprazole Sodium | Pantoprazole Sodium | 304 | 45 |
| Metoprolol Succinate | Metoprolol Succinate | 288 | 29 |
| Famotidine | Famotidine | 214 | 23 |
| Memantine Hcl | Memantine Hcl | 206 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 203 | 21 |
| Trazodone Hcl | Trazodone Hcl | 202 | 23 |
| Losartan Potassium | Losartan Potassium | 195 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 169 | 18 |
| Lisinopril | Lisinopril | 161 | 22 |
| Metformin Hcl | Metformin Hcl | 161 | 18 |
| Spironolactone | Spironolactone | 160 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 146 | 22 |
| Gabapentin | Gabapentin | 123 | 20 |
| Sertraline Hcl | Sertraline Hcl | 122 | 14 |
| Omeprazole | Omeprazole | 121 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 119 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 115 | suppressed |
| Jardiance | Empagliflozin | 113 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 104 | 14 |
| Allopurinol | Allopurinol | 103 | 12 |
| Tramadol Hcl | Tramadol Hcl | 96 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 93 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 93 | 11 |
| Mirtazapine | Mirtazapine | 93 | 12 |
| Buspirone Hcl | Buspirone Hcl | 92 | suppressed |
| Finasteride | Finasteride | 87 | suppressed |
| Latanoprost | Latanoprost | 87 | 18 |
| Warfarin Sodium | Warfarin Sodium | 86 | suppressed |
| Lorazepam | Lorazepam | 79 | 15 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 77 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 75 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 69 | 14 |
| Meloxicam | Meloxicam | 68 | 13 |
| Atenolol | Atenolol | 62 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 61 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 58 | suppressed |
| Xarelto | Rivaroxaban | 57 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 54 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 52 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 51 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 51 | suppressed |
| Primidone | Primidone | 51 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 48 | suppressed |
| Carvedilol | Carvedilol | 45 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 45 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 42 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 42 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 41 | 12 |
| Nyamyc | Nystatin | 41 | 16 |
| Farxiga | Dapagliflozin Propanediol | 38 | suppressed |
| Olanzapine | Olanzapine | 38 | suppressed |
| Baclofen | Baclofen | 37 | suppressed |
| Nystatin | Nystatin | 36 | 21 |
| Simvastatin | Simvastatin | 36 | suppressed |
| Cefdinir | Cefdinir | 35 | 24 |
| Clonazepam | Clonazepam | 35 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 35 | 19 |
| Prednisone | Prednisone | 35 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Levetiracetam | Levetiracetam | 34 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 32 | suppressed |
| Azithromycin | Azithromycin | 31 | 20 |
| Calcium Acetate | Calcium Acetate | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | 11 |
| Midodrine Hcl | Midodrine Hcl | 29 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 29 | 17 |
| Digoxin | Digoxin | 28 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 11 |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 26 | suppressed |
| Januvia | Sitagliptin Phosphate | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 25 | suppressed |
| Entacapone | Entacapone | 25 | suppressed |
| Aripiprazole | Aripiprazole | 24 | suppressed |
| Haloperidol | Haloperidol | 24 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 15 |
| Chlorthalidone | Chlorthalidone | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 22 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 22 | suppressed |
| Methocarbamol | Methocarbamol | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Loperamide | Loperamide Hcl | 20 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 20 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 19 | suppressed |
| Calcitriol | Calcitriol | 18 | suppressed |
| Colchicine | Colchicine | 18 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Cephalexin | Cephalexin | 16 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 16 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Glatopa | Glatiramer Acetate | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 15 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 15 | suppressed |
| Timolol Maleate | Timolol Maleate | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Mirabegron Er | Mirabegron | 14 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Renvela | Sevelamer Carbonate | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 11 | 11 |
| Dutasteride | Dutasteride | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $96.62 · 1 records | SK Life Science, Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error